Caroline M.P.W. Mandigers
- Oncology top 5%
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 4
- Cancer survivorship and care 3
- HER2/EGFR in Cancer Research 3
- Cancer Research top 5%
- Breast Cancer Treatment Studies 5
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 5
- Pharmacology top 10%
-
- Palliative Care and End-of-Life Issues 5
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- John RaemaekersEvelyn TönnissenJules P.P. MeijerinkFederico GoodsaidLouis van de LochtErik van WerkhovenMarcel SoesanJan H.M. Schellens
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Caroline M.P.W. Mandigers
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Oncology 688
- Cancer Research 318
- Pathology and Forensic Medicine 163
- Pharmacology 62
- Genetics 56
Countries citing papers authored by Caroline M.P.W. Mandigers
This map shows the geographic impact of Caroline M.P.W. Mandigers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline M.P.W. Mandigers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline M.P.W. Mandigers more than expected).
Fields of papers citing papers by Caroline M.P.W. Mandigers
This network shows the impact of papers produced by Caroline M.P.W. Mandigers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline M.P.W. Mandigers. The network helps show where Caroline M.P.W. Mandigers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caroline M.P.W. Mandigers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 25 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 24 | |
| 10 | 2018 | 245 | |
| 11 | 2018 | 1 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 5 | |
| 14 | 2017 | 81 | |
| 15 | 2015 | 29 | |
| 16 | 2015 | 7 | |
| 17 | 2013 | 38 | |
| 18 | [Prevention of severe toxicity from capecitabine, 5-fluorouracil and tegafur by screening for DPD-deficiency]. | 2012 | 6 |
| 19 | Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma. | 2003 | 20 |
| 20 | 2001 | 257 |
About Caroline M.P.W. Mandigers
Caroline M.P.W. Mandigers is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Palliative Care and End-of-Life Issues (5 papers), Advanced Breast Cancer Therapies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer survivorship and care (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (688 citations), Cancer Research (318 citations) and Pathology and Forensic Medicine (163 citations). Caroline M.P.W. Mandigers has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include John Raemaekers, Evelyn Tönnissen, Jules P.P. Meijerink, Federico Goodsaid, Louis van de Locht, Erik van Werkhoven, Marcel Soesan, Jan H.M. Schellens, Maarten J. Deenen and Annemieke Cats. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.